Myriad Genetics Raises 2026 Revenue Outlook Midpoint to $785 Million
Image: TokenPost
The company set a range of $780 million to $790 million as higher revenue per test partly offsets expected Prenatal Health softness.
Read the full story on TokenPostBeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.
